Related Experiment Video
Updated: Jul 15, 2026
12:04
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
[Study for an allergic inflammation model using human lungs and its pharmacological application].
Hiroshi Hama1, Nobufumi Ono, Masayoshi Abe
1Pharmaco-Informatics Research Unit, Faculty of Pharmaceutical Sciences, Fukuoka University, Japan.
Summary
The complement system
Area of Science:
- Immunology
- Allergic Inflammation
- Complement System Biology
Context:
- Allergic asthma involves airway inflammation, bronchoconstriction, and mucus secretion, with Th2 cytokines and cysteinyl-leukotrienes (CysLTs) as key mediators.
- Species differences in complement molecules complicate animal models for studying asthma drug effects.
- The complement system's role in innate immunity is crucial for understanding allergic asthma pathophysiology.
Purpose:
- To establish a human lung model for evaluating drug effects on CysLT production during anaphylaxis.
- To investigate the role of complement anaphylatoxins, specifically C5a and C3a, in potentiating CysLT release.
- To assess the efficacy of C5a receptor antagonists in inhibiting CysLT production.
Summary:
- Stimulation of human lung tissue with anti-IgE antibody increased CysLT production, which was further potentiated by C5a.
- C5a demonstrated a stronger effect on CysLT production compared to C3a.
- The C5a-mediated increase in CysLTs was dose-dependently inhibited by W-54011 and acetyl peptide A.
Impact:
- C5a significantly enhances CysLT production in human lung tissues, contributing to allergic inflammation.
- These findings suggest C5a is a key mediator in asthma pathophysiology.
- Acetyl peptide A and W-54011 show potential as therapeutic agents for suppressing allergic lung inflammation.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...